Moss, 11 February 2020 Gentian Diagnostics AS announces its results for the 4th quarter and 2020 preliminary..
Moss, 22.01.2021 Gentian Diagnostics AS is pleased to announce that its high-throughput SARS-CoV-2 antibody..
Moss, Norway 20.11.2020 Gentian Diagnostics AS is pleased to announce that the results from a study conducted..
Gentian Diagnostics today announces the divestiture of its subsidiary PreTect AS to Mel-Mont Medical, Inc...
Gentian Diagnostics AS will present its 2020 third quarter results on October 29th at 10.00 am.